NCT01905813 2025-12-19
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
Incyte Corporation
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT02457598 2025-06-17
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
Gilead Sciences
Phase 1 Terminated
NCT06958679 2025-05-14
Evaluation of SYS6005 in Patients With Advanced Malignant Tumor
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1 Recruiting
NCT04551963 2024-10-26
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeiGene
Phase 1 Completed